Zhe Sha, Harvard Medical School, USA
Its my real honor to be part of this great conference. I had a truly rewarding experience meeting with many experts in the field.
OMICS Group is dedicated to serve the scientific community through its 350 leading Open access peer reviewed Journals supported by 30,000 renowned editorial board and more than 3 million readers worldwide. OMICS Group International is proud to host around 100 International Conferences around the globe to address the current issues and discoveries in the field of Life sciences, Engineering, Medical and Management. OMICS group scientific events are the special designed cluster of program that provides a common platform where industry meets academia to discuss the recent issues and happening. OMICS Group international congresses serve as a bridge between researchers from academia and industry enhanced by its well organized scientific sessions, plenary lectures, poster presentations, world class exhibitions, diverse symposiums, highly enriched workshops and B2B meetings.
With the success of conference on various clinical, medical and management science, OMICS Group for the fifth time is going to organize a conference on 5th World Congress on Diabetes & Metabolism to be held on November 03-05, 2014 Las Vegas, USA. The previous four Diabetes congresses were held at Santa Clara-USA, Philadelphia-USA, Hyderabad-India and Chicago-USA had achieved a grand success. Now it is the time for the 5th World Congress on Diabetes to address new challenges and emerging issues in Diabetes. Diabetes is the premier event that brings together a unique and International mix of experts, researchers and decision makers both from academia and industry across the globe to exchange their knowledge, experience and research innovations to build a world Diabetes community.
Clinical Diabetes and Diagnostic Approaches
Diabetes and its Complications
Endocrinology: Disorders & Treatment
Advanced Technologies for Treatment of Diabetes
Advancement of New Drug/Biomarker Discovery for Treatment of Diabetes
Genetics of Diabetes
Emerging Focus in Diabetes Research
Transplantation for Diabetes
Diabetes will also provide the excellent opportunity to meet Physicians, Researchers, Clinicians, Experts, Directors, Professors, Associate Professors, Podiatrists, Pharmacists, Physician assistants, Nurse practitioners, Nurses, Dietitians, Certified diabetes educators, other health care professionals and who manage diabetes related complications. We look forward to meet you in November 2014, and hoping that you will have a fruitful experience.
The term diabetes mellitus includes several different metabolic disorders, results in abnormally high concentrations of a sugar called glucose in the blood. DM type 1 results when the pancreas no longer produces significant amounts of the insulin, owing to the destruction of the insulin-producing beta cells of the pancreas. DM type 2, in contrast, results from insulin resistance.
The metabolic syndrome refers to a clustering of cardiovascular disease (CVD) risk factors whose underlying pathophysiology may be related to insulin resistance.
Hypoglycemia means “low blood sugar”. Hypoglycemia is treated by restoring the glucose level to traditional by the uptake or administration of glucose or macromolecule foods.
The number of people diagnosed with diabetes has risen from 1.5 million in 1958 to 18.8 million in 2010, an increase of diabetes epidemiological proportions. Diabetes is the seventh leading cause of death listed on U.S. death certificates. Cardiovascular disease is the leading cause of death among people with diabetes — about 68 percent die of heart disease or stroke. Overweight and obesity are driving the global diabetes epidemic. They affect the majority of adults in most developed countries and are increasing rapidly in developing countries.